Reddy医生推出新的癌症药物Zytorvi 治疗印度罕见的头部和颈部癌。 Dr. Reddy's launches new cancer drug Zytorvi to treat a rare head and neck cancer in India.
Reddy博士的实验室已经推出Toripalimab, 一种经美国和欧洲监管者批准的新型免疫肿瘤药物, Dr. Reddy's Laboratories has launched Toripalimab, a new immuno-oncology drug approved by US and European regulators, to treat a rare and aggressive form of head and neck cancer called nasopharyngeal carcinoma (NPC) in India. 作为Zytorvi市场,它是继中国和美国之后获得这一先进的PD-1抑制剂的第三个国家。 Marketed as Zytorvi, it is the third country to receive this advanced PD-1 inhibitor, following China and the US. 以前,化疗是印度治疗这种癌症的标准方法。 Previously, chemotherapy was the standard treatment for this cancer in India.